05/16/2025
8:23 AM | Rein Therapeutics, Inc. (Filer)
Rein Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
05/15/2025
3:06 PM | Rein Therapeutics, Inc. (Filer)
Rein Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/14/2025
7:26 PM | Rein Therapeutics, Inc. (Subject)
Rein Therapeutics (Subject)
Voss Capital, LP (Filed by)
| Form SCHEDULE 13G | |
05/12/2025
3:30 PM | Rein Therapeutics, Inc. (Filer)
Rein Therapeutics (Filer)
| Form DEF 14A | |
05/12/2025
3:32 PM | Rein Therapeutics, Inc. (Filer)
Rein Therapeutics (Filer)
| Form DEFA14A | |
04/30/2025
4:27 PM | Rein Therapeutics, Inc. (Filer)
Rein Therapeutics (Filer)
| Form 10-K/A | |
04/22/2025
7:58 AM | Rein Therapeutics, Inc. (Filer)
Rein Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/07/2025
3:02 PM | Rein Therapeutics, Inc. (Filer)
Rein Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/31/2025
4:07 PM | Rein Therapeutics, Inc. (Filer)
Rein Therapeutics (Filer)
| Form NT 10-K | |
12/06/2024
3:34 PM | Aileron Therapeutics, Inc. (Issuer)
Rein Therapeutics (Issuer)
VON RICKENBACH JOSEF H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2024
3:35 PM | Aileron Therapeutics, Inc. (Issuer)
Rein Therapeutics (Issuer)
Fairey William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for RNTX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Rein Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
12/06/2024
3:38 PM | Aileron Therapeutics, Inc. (Issuer)
Rein Therapeutics (Issuer)
Ambros Reinhard J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2024
3:41 PM | Aileron Therapeutics, Inc. (Issuer)
Rein Therapeutics (Issuer)
Aivado Manuel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
3:03 PM | Aileron Therapeutics, Inc. (Filer)
Rein Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/05/2024
4:17 PM | Aileron Therapeutics, Inc. (Subject)
Rein Therapeutics (Subject)
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO (Filed by)
| Form SCHEDULE 13G/A | |
08/22/2024
3:05 PM | Aileron Therapeutics, Inc. (Issuer)
Rein Therapeutics (Issuer)
Musso Alan A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
3:06 PM | Aileron Therapeutics, Inc. (Issuer)
Rein Therapeutics (Issuer)
Ambros Reinhard J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
3:06 PM | Aileron Therapeutics, Inc. (Issuer)
Rein Therapeutics (Issuer)
Fairey William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
3:07 PM | Aileron Therapeutics, Inc. (Issuer)
Rein Therapeutics (Issuer)
VON RICKENBACH JOSEF H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
3:09 PM | Aileron Therapeutics, Inc. (Issuer)
Rein Therapeutics (Issuer)
Aivado Manuel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
4:12 PM | Aileron Therapeutics, Inc. (Filer)
Rein Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/14/2024
4:23 PM | Aileron Therapeutics, Inc. (Filer)
Rein Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/26/2024
3:29 PM | Aileron Therapeutics, Inc. (Filer)
Rein Therapeutics (Filer)
| Form 424B5 | |
07/26/2024
3:33 PM | Aileron Therapeutics, Inc. (Filer)
Rein Therapeutics (Filer)
| Form 424B5 | |
07/26/2024
3:36 PM | Aileron Therapeutics, Inc. (Filer)
Rein Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/09/2024
7:41 AM | Aileron Therapeutics, Inc. (Filer)
Rein Therapeutics (Filer)
| Form ARS | |
07/09/2024
7:30 AM | Aileron Therapeutics, Inc. (Filer)
Rein Therapeutics (Filer)
| Form DEF 14A | |
07/09/2024
7:36 AM | Aileron Therapeutics, Inc. (Filer)
Rein Therapeutics (Filer)
| Form DEFA14A | |
06/17/2024
6:03 PM | Aileron Therapeutics, Inc. (Issuer)
Rein Therapeutics (Issuer)
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2024
5:18 PM | Aileron Therapeutics, Inc. (Issuer)
Rein Therapeutics (Issuer)
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
5:59 PM | Aileron Therapeutics, Inc. (Issuer)
Rein Therapeutics (Issuer)
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
5:58 AM | Aileron Therapeutics, Inc. (Filer)
Rein Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
